It's 'Put Up or Shut Up' time next Tuesday.......
Micromet to Host Conference Call and Webcast to Discuss MT110 Data Presented at ECCO/ESMO on September 22, 2009
3:02 pm ET 09/17/2009- PR Newswire
BETHESDA, Md., Sept. 17 /PRNewswire-FirstCall/ -- Micromet, Inc. (Nasdaq: MITI), a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, today announced that it will host a conference call and webcast on September 22, 2009 at 7:00 am U.S. Eastern Time to discuss the data from a phase 1 clinical trial with Micromet's anti-EpCAM BiTE antibody MT110, which was presented on September 21, 2009 at the joint 15th Congress of the European CanCer Organisation (ECCO) and 34th Congress of the European Society for Medical Oncology (ESMO) in Berlin, Germany. The webcast will be available on the company's website at www.micromet-inc.com.
Forum: Micromet, Inc. Conference Call and Webcast
Date: Tuesday, September 22, 2009
Time: 7:00 am to 7:30 am U.S. Eastern Time
Webcast: www.micromet-inc.com |
